For boosting the number of well-performing study sites, minimizing risk in site selection and significantly shortening the time duration of patient recruitment, we have introduced our data-driven site pre-classification program called ACCELEROUTE™. Our teams are continuing to expand and deliver quality data to exceed our Customers’ expectations with accelerated study operations and on-time, on budget project delivery.

In 2017, we expanded our operations to the Asian market by opening a new office in Gurgaon, India. This investment provides our Biotechnology, Pharmaceutical and Medical Device Customers with greater access to patient populations in an increasingly well-regulated environment. We celebrated our 15th anniversary being globally active in the clinical research arena as a full-service CRO.

In 2016, Accelsiors launched the Annual Biosimilars Forum professional event series in cooperation with our prestigious international scientific institute partners (the Viennese Section of the IBS and the Hungarian Society for Clinical Biostatistics), in order to provide even more effective support in sharing of recent scientific and practical knowledge for professionals who are working in and for biosimilar drug development.

In 2015, we introduced our PACE initiative to further strengthen and harmonize study project management processes and procedures. We implemented a weekly recruitment booster initiative to complement our monthly Project Review Meetings and completed the hiring of our Senior Management Team.

IT and HR were expanded to manage the demands of a growing organization. Today we can deploy our services on any location you need with operations in 40 countries around the globe (Europe, MENA, Asia and North America) and collaboration with our trusted CRO subcontractors in the rest of the world.

As our team broadened continually, we added teams in Logistics, Training, Pharmacovigilance and Medical monitoring. In 2007, we established our Biometrics department to include our talented data managers, statisticians and medical writers.

In 2003, we expanded to include project management and established our Quality Assurance department. Our reputation for delivery was recognized and we were soon involved in multicenter global studies offering full service.

Accelsiors CRO Ltd. was established by senior drug development professionals in Budapest, Hungary in 2002. Initial activities were related to regulatory consultancy services and as Customers requested, services were broadened to include clinical monitoring services with complementary SOPs.